Table 1 Participant Demographics
| Â | n (%) |
|---|---|
Study site | |
 Princess Margaret | 65 (85.5%) |
 Sunnybrook | 11 (14.5%) |
Age at diagnosis | |
 Mean (SD) | 62.0 (10.7) |
 Minimum, Maximum | 38, 84 |
Ovarian cancer stage | |
 I/II | 9 (11.8%) |
 III/IV | 67 (88.2%) |
Primary treatment | |
 Neoadjuvant chemotherapy | 33 (43.4%) |
 Primary surgery | 43 (56.6%) |
Personal history breast cancer | |
 Yes | 6 (7.9%) |
 No | 70 (92.1%) |
Family history breast or ovarian Cancer | |
 Yes | 34 (44.7%) |
 No | 42 (55.3%) |
Previous genetic testing in the family | |
 Yes | 11 (14.7%) |
 No | 64 (85.3%) |
Pre-test counselling prior to survey | |
 Yes | 31 (40.8%) |
 No | 45 (59.2%) |
Tumour genetic test result | |
 Positive (BRCA1/2 pathogenic variant identified) | 23 (30.3%) |
 Negative | 53 (69.7%) |
Relationship Status | |
 Partnered | 43 (57.3%) |
 Not partnered | 32 (42.7%) |
 Missing | 1 |
Children | |
 Children | 43 (56.6%) |
 No children | 33 (43.4%) |
Education and training | |
 Postsecondary education/training | 61 (82.4%) |
 Secondary school or less | 13 (17.6%) |
 Missing | 2 |
Household income | |
 75 K or greater | 24 (50.0%) |
 Less than 75 K | 24 (50.0%) |
 Missing | 28 |
Race/Ethnicity | |
 White | 52 (71.2%) |
 Other | 21 (28.8%) |
 Missing | 3 |